You have 9 free searches left this month | for more free features.

Impulse Control Disorder

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Emotion Regulation, Mood Disorders, Stress Disorder Trial in Durham (Active Repetitive Transcranial Magnetic Stimulation (rTMS),

Not yet recruiting
  • Emotion Regulation
  • +13 more
  • Active Repetitive Transcranial Magnetic Stimulation (rTMS)
  • +3 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 25, 2023

Alcohol Use Disorder, Intermittent Explosive Disorder Trial in Columbus (Alcohol (Ethanol), Placebo)

Recruiting
  • Alcohol Use Disorder
  • Intermittent Explosive Disorder
  • Alcohol (Ethanol)
  • Placebo
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 1, 2023

Intermittent Explosive Disorder Trial in Columbus (Nitrous oxide, Room Air)

Recruiting
  • Intermittent Explosive Disorder
  • Nitrous oxide
  • Room Air
  • Columbus, Ohio
    Ohio State University Wexner Medical Center
Nov 1, 2023

Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)

Completed
  • Impulse Control Disorder
  • Anyang, Korea, Republic of
  • +4 more
Mar 9, 2021

Intermittent Explosive Disorder Trial in Columbus (Pimavanserin 34 mg, Placebo)

Not yet recruiting
  • Intermittent Explosive Disorder
  • Pimavanserin 34 mg
  • Placebo
  • Columbus, Ohio
    The Ohio State University College of Medicine
May 31, 2023

Bipolar Affective Disorder Trial in Moscow (Quetiapine)

Recruiting
  • Bipolar Affective Disorder
  • Moscow, Russian Federation
    Mental health research center
Oct 18, 2021

Modified DECIDE Intervention, Treatment as Usual Care Group Trial in Indianapolis (Modified DECIDE Parent and Provider

Recruiting
  • Modified DECIDE Intervention
  • Treatment as Usual Care Group
  • Modified DECIDE Parent and Provider Intervention
  • Sarasota, Florida
  • +4 more
Oct 31, 2022

Parkinson's Disease, Mpulse Control Disorders Trial in Bron (, Clonidine)

Completed
  • Parkinson's Disease
  • Mpulse Control Disorders
  • Bron, France
    Hospices Civils de Lyon
Jan 18, 2022

Intermittent Explosive Disorder Trial in Chicago (Fluoxetine, Divalproex, Placebo)

Completed
  • Intermittent Explosive Disorder
  • Chicago, Illinois
    The University of Chicago
Apr 26, 2021

Intermittent Explosive Disorder Trial in Philadelphia (Cognitive Bias Modification, Cognitive Bias Control)

Not yet recruiting
  • Intermittent Explosive Disorder
  • Cognitive Bias Modification
  • Cognitive Bias Control
  • Philadelphia, Pennsylvania
    Temple University
Mar 25, 2021

Chronic Pain, Knee Pain Chronic, Back Pain, Low Trial in San Francisco (HFIT, TENS, Control)

Not yet recruiting
  • Chronic Pain
  • +2 more
  • HFIT
  • +2 more
  • San Francisco, California
    Hinge Health, Inc
Apr 18, 2023

Binge-Eating Disorder Trial in Tübingen (Behavioral training and verum stimulation, Behavioral training and sham stimulation)

Completed
  • Binge-Eating Disorder
  • Behavioral training and verum stimulation
  • Behavioral training and sham stimulation
  • Tübingen, Germany
    University Hospital Tübingen
May 23, 2022

Attention Deficit/Hyperactivity Disorder Trial in Boston (Oxytocin nasal spray, Placebo nasal spray)

Completed
  • Attention Deficit/Hyperactivity Disorder
  • Oxytocin nasal spray
  • Placebo nasal spray
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 30, 2022

PTSD Trial (Transcranial Magnetic Stimulation (TMS))

Not yet recruiting
  • PTSD
  • Transcranial Magnetic Stimulation (TMS)
  • (no location specified)
Aug 30, 2023

ADHD, Executive Dysfunction Trial (Goal Management training)

Not yet recruiting
  • Attention Deficit Hyperactivity Disorder
  • Executive Dysfunction
  • Goal Management training
  • (no location specified)
May 26, 2023

OCD in Children Trial in New York (Cognitive Control Training (CT))

Not yet recruiting
  • Obsessive-Compulsive Disorder in Children
  • Cognitive Control Training (CT)
  • New York, New York
    New York State Psychiatric Institute
Oct 22, 2023

Parkinson Disease Trial in France (drug, behavioral, procedure)

Recruiting
  • Parkinson Disease
  • Active drug: pimavanserin 17mg (2 strength tablets)
  • +9 more
  • Besançon, France
  • +15 more
Jan 20, 2022

Vestibular Disorder Trial (Vestibular training using VR followed by Control, Control followed by Vestibular training using VR)

Not yet recruiting
  • Vestibular Disorder
  • Vestibular training using VR followed by Control
  • Control followed by Vestibular training using VR
  • (no location specified)
Jul 10, 2023

Multispectral Optoacoustic Tomography in Cystic Fibrosis

Not yet recruiting
  • Cystic Fibrosis
  • +3 more
  • Acoustic Radiation Forced Impulse Imaging
  • Multispectral Optoacoustic Tomography
  • Erlangen, Bavaria, Germany
    University Hospital Erlange, Department of Pediatrics
Sep 25, 2023

Bipolar Disorder, Bipolar I Disorder, Bipolar Affective Disorder Trial in Chicago (Cognitive Control of Emotion (CCE) Training)

Completed
  • Bipolar Disorder
  • +4 more
  • Cognitive Control of Emotion (CCE) Training
  • Chicago, Illinois
    Rush University Medical Center
Jan 12, 2023

Autism Spectrum Disorder Trial (Postural Control Balance Assessment)

Completed
  • Autism Spectrum Disorder
  • Postural Control Balance Assessment
  • (no location specified)
Dec 8, 2022

MDD Trial in San Francisco (Intervention app, Control app)

Not yet recruiting
  • Major Depressive Disorder
  • Intervention app
  • Control app
  • San Francisco, California
    Big Health, Inc.
Aug 29, 2023

Tourette Disorder Trial in Bron, Paris (Administration of a PET radiotracer)

Not yet recruiting
  • Tourette Disorder
  • Administration of a PET radiotracer
  • Bron, France
  • +1 more
Jul 12, 2023

Attentional Biases, Reward Sensitivity, and Cognitive Control in

Recruiting
  • Bipolar Disorder
  • Eye tracking
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center - Mood Disorders P
Sep 29, 2022

Teenagers, Drug Addiction, and Reward and Impulse Control

Withdrawn
  • Adolescents
  • +2 more
    • (no location specified)
    Dec 11, 2019